Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Slim Fourati

Showing results (91-100 of 185) with videos related to

Pageof 19
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 29, 2021
Neutralization Heterogeneity of UK and South African Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants in BNT162b2-Vaccinated or Convalescent Coronavirus Disease 2019 (COVID-19) Healthcare WorkersStéphane Marot, Isabelle Malet, Valentin Leducq, et al.
Plos One|August 1, 2012
Similar evolution of cellular HIV-1 DNA level in darunavir/ritonavir monotherapy versus triple therapy in MONOI-ANRS136 trial over 96 weeksSidonie Lambert-Niclot, Philippe Flandre, Marc-Antoine Valantin, et al.
Antimicrobial Agents and Chemotherapy|May 16, 2018
Characterization of the Anti-Hepatitis C Virus Activity of New Nonpeptidic Small-Molecule Cyclophilin Inhibitors with the Potential for Broad Anti-Flaviviridae ActivityQuentin Nevers, Isaac Ruiz, Nazim Ahnou, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|December 4, 2021
Performance of a high-throughput, automated enzyme immunoassay for the detection of SARS-CoV-2 antigen, including in viral "variants of concern": Implications for clinical useSlim Fourati, Alexandre Soulier, Aurélie Gourgeon, et al.
Transplantation|August 28, 2020
De Novo Focal and Segmental Glomerulosclerosis After COVID-19 in a Patient With a Transplanted Kidney From a Donor With a High-risk APOL1 VariantJulie Oniszczuk, Anissa Moktefi, Aude Mausoleo, et al.
American Journal of Respiratory Cell and Molecular Biology|May 30, 2025
Airway Immune Signatures in Severe and Fatal Infection with COVID-19Naresh Doni Jayavelu, Jing Jing Qi, Slim Fourati, et al.
Bone Marrow Transplantation|September 22, 2021
Evaluation of prognostic scores for respiratory syncytial virus infection in a French multicentre cohort of allogeneic haematopoietic stem cell transplantation recipientsAnne-Laure Houist, Louise Bondeelle, Maud Salmona, et al.
The Lancet. Haematology|April 4, 2022
Impact of donor vaccination on recipient response to early SARS-CoV-2 mRNA vaccination after allogeneic HSCTMathieu Leclerc, Rabah Redjoul, Anne Le Bouter, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 13, 2023
Prognosis of hospitalised adult patients with respiratory syncytial virus infection: a multicentre retrospective cohort studyHéloïse Celante, Nadia Oubaya, Slim Fourati, et al.
Journal of Clinical Immunology|February 22, 2021
Plasma Exchange to Rescue Patients with Autoantibodies Against Type I Interferons and Life-Threatening COVID-19 PneumoniaNicolas de Prost, Paul Bastard, Romain Arrestier, et al.
Pageof 19

Showing results (91-100 of 185) with videos related to

Sort By:
Pageof 19
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 29, 2021
Neutralization Heterogeneity of UK and South African Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants in BNT162b2-Vaccinated or Convalescent Coronavirus Disease 2019 (COVID-19) Healthcare WorkersStéphane Marot, Isabelle Malet, Valentin Leducq, et al.
Plos One|August 1, 2012
Similar evolution of cellular HIV-1 DNA level in darunavir/ritonavir monotherapy versus triple therapy in MONOI-ANRS136 trial over 96 weeksSidonie Lambert-Niclot, Philippe Flandre, Marc-Antoine Valantin, et al.
Antimicrobial Agents and Chemotherapy|May 16, 2018
Characterization of the Anti-Hepatitis C Virus Activity of New Nonpeptidic Small-Molecule Cyclophilin Inhibitors with the Potential for Broad Anti-Flaviviridae ActivityQuentin Nevers, Isaac Ruiz, Nazim Ahnou, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|December 4, 2021
Performance of a high-throughput, automated enzyme immunoassay for the detection of SARS-CoV-2 antigen, including in viral "variants of concern": Implications for clinical useSlim Fourati, Alexandre Soulier, Aurélie Gourgeon, et al.
Transplantation|August 28, 2020
De Novo Focal and Segmental Glomerulosclerosis After COVID-19 in a Patient With a Transplanted Kidney From a Donor With a High-risk APOL1 VariantJulie Oniszczuk, Anissa Moktefi, Aude Mausoleo, et al.
American Journal of Respiratory Cell and Molecular Biology|May 30, 2025
Airway Immune Signatures in Severe and Fatal Infection with COVID-19Naresh Doni Jayavelu, Jing Jing Qi, Slim Fourati, et al.
Bone Marrow Transplantation|September 22, 2021
Evaluation of prognostic scores for respiratory syncytial virus infection in a French multicentre cohort of allogeneic haematopoietic stem cell transplantation recipientsAnne-Laure Houist, Louise Bondeelle, Maud Salmona, et al.
The Lancet. Haematology|April 4, 2022
Impact of donor vaccination on recipient response to early SARS-CoV-2 mRNA vaccination after allogeneic HSCTMathieu Leclerc, Rabah Redjoul, Anne Le Bouter, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 13, 2023
Prognosis of hospitalised adult patients with respiratory syncytial virus infection: a multicentre retrospective cohort studyHéloïse Celante, Nadia Oubaya, Slim Fourati, et al.
Journal of Clinical Immunology|February 22, 2021
Plasma Exchange to Rescue Patients with Autoantibodies Against Type I Interferons and Life-Threatening COVID-19 PneumoniaNicolas de Prost, Paul Bastard, Romain Arrestier, et al.
Pageof 19